SecBot SecBot
144 ·Filed Nov 10, 2026

NBIX

NEUROCRINE BIOSCIENCES INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed6d 9h ago SEC0001950047-26-010964
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine advance notice of a planned sale by a former affiliate, not a current executive or board member. The sale is small relative to market cap and appears to be a standard exercise-and-sell of options. No material impact is expected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$174.41
T+0 close · Nov 10, 2026 · via day close
Latest settled
−2.87%
T+1 · $169.40
Vs SPY
−2.52%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 11 $174.41entry
  2. T+1 · 5d ago −2.87%α −2.52% · $169.40
  3. T+3 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 23d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Sanjay Keswani, a former affiliate of Neurocrine Biosciences, filed a Form 144 notice of intent to sell 53,614 shares of common stock, with an approximate market value of $8.97 million based on the filing date. The shares were acquired through exercise of options under a registered plan, and the sale is planned for execution on the same day as the filing.

Key Facts

  • Sanjay Keswani, a former affiliate, filed Form 144 to sell 53,614 shares of Neurocrine Biosciences common stock.
  • The approximate market value of the proposed sale is $8,973,487.77.
  • The shares were acquired through exercise of options under a registered plan on November 10, 2026.
  • The sale is planned for execution on November 10, 2026, on the Nasdaq exchange.
  • The filing represents about 0.05% of the company's $16.7B market cap.

Financial Impact

Proposed sale of 53,614 shares valued at approximately $8.97 million, representing about 0.05% of market cap.

dilution

Risk Factors

  • The sale may signal the insider's desire to monetize options, but as a former affiliate, the signal is weaker than a current executive sale.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (37 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010964
Document: 0001950047-26-010964-index.html0001950047-26-010964
Document: 0001950047-26-010964.txt0001950047-26-010964

Track record

30 reports on NBIX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +27.40% at T+60 after the Apr 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Viewing Entry $174.41 Now $165.31 −5.22% settles Dec 10
  2. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  3. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  4. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
  5. Nov 2, 202614d ago Press Release Bullish 6/10 No price data
  6. Nov 2, 202614d ago 144 Neutral 2/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
  7. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
  8. Oct 30, 202617d ago 144 Neutral 1/10 Entry $145.35 Now $165.31 +13.73% settles Dec 1
  9. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $146.10 Now $165.31 +13.15% settles Nov 30
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $145.53 Now $165.31 +13.59% settles Nov 25
Showing 10 of 30

US Market Status

Market Closed · Opens in 6h 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026